Sleep and sleep disorders in chronic users of zopiclone and drug-free insomniacs

Journal of Clinical Sleep Medicine

Volumn 5, Issue 4, 2009, Pages 349-354

  Sivertsen, Børge ^a   Omvik, Siri ^a   Pallesen, Ståle ^a,b   Nordhus, Inger Hilde ^a,b   Bjorvatn, Bjørn ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Periodic limb movement disorder; PLMD; Sleep apnea; Sleep disorders; Sleep medications

Indexed keywords

ZOPICLONE;

ADULT; AGED; ANXIETY; ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; DRUG USE; FEMALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PERIODIC LIMB MOVEMENT DISORDER; POLYSOMNOGRAPHY; PREVALENCE; SLEEP; SLEEP APNEA SYNDROME; SLEEP DISORDER; SLEEP PARAMETERS; SLEEP PATTERN; SLOW WAVE SLEEP; WAKEFULNESS;

EID: 70349147353     PISSN: 15509389     EISSN: 15509397     Source Type: Journal    
DOI: 10.5664/jcsm.27546     Document Type: Article

References (63)

1. Saul S. Record sales of sleeping pills are causing worries. The New York Times February 7, 2006.
2. Saul S. Sleep drugs found only mildly effective, but wildly popular. The New York Times October 23, 2007.
3. Ohayon M, Caulet M, Lemoine P. Sujets âgés, habitudes de sommeil et consommation de psychotropes dans la population française. L'Encéphale 1996;22:337-350
4. Woods J, Katz J, Winger G. Benzodiazepines: use, abuse, and consequences. Pharmacol Rev 1992;44:151-347.
5. Kripke DF. Chronic hypnotic use: deadly risks, doubtful benefit. Sleep Med Rev 2000;4:5-20.
6. Kripke DF, Klauber MR, Wingard DL, Fell RL, Assmus JD, Garfinkel L. Mortality hazard associated with prescription hypnotics. Biol Psychiatry 1998;43:687-693
7. Walsh JK, Krystal AD, Amato DA, et al. Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations. Sleep 2007;30:959-968
8. NIH State-of-the-Science Conference Statement on Manifestations and Management of Chronic Insomnia in Adults. NIH Consens State Sci Statements 2005 Jun 13-15;22:1-30.
9. Glass J, Lanctot KL, Herrmann N, Sproule BA, Busto UE. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ 2005;331:1169. (Pubitemid 41689427)
10. Mendelson W. Hypnotic medications: mechanisms of action and pharmacologic effects. In: Kryger MH, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine, 4th ed. Philadelphia, PA: WB Saunders; 2005:444-451
11. Nakajima T, Sasaki T, Nakagome K, et al. Comparison of the effects of zolpidem and zopiclone on nocturnal sleep and sleep latency in the morning: a cross-over study in healthy young volunteers. Life Sci 2000;67:81-90. (Pubitemid 30368625)
12. Hemmeter U, Muller M, Bischof R, Annen B, Holsboer-Trachsler E. Effect of zopiclone and temazepam on sleep EEG parameters, psychomotor and memory functions in healthy elderly volunteers. Psychopharmacology (Berl) 2000;147:384-396 (Pubitemid 30048486)
13. Sivertsen B, Omvik S, Pallesen S, et al. Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial. JAMA 2006;295:2851-2858 (Pubitemid 43974182)
14. Dubois S, Bedard M, Weaver B. The impact of benzodiazepines on safe driving. Traffic Inj Prev 2008;9:404-413
15. Gustavsen I, Bramness JG, Skurtveit S, Engeland A, Neutel I, Morland J. Road traffic accident risk related to prescriptions of the hypnotics zopiclone, zolpidem, flunitrazepam and nitrazepam. Sleep Med 2008;9:818-822
16. Allgulander C. History and current status of sedative-hypnotic drug use and abuse. Acta Psychiatr Scand 1986;73:465-478 (Pubitemid 16091036)
17. Allgulander C, Nasman P. Regular hypnotic drug treatment in a sample of 32,679 Swedes: associations with somatic and mental health, inpatient psychiatric diagnoses and suicide, derived with automated record-linkage. Psychosom Med 1991;53:101-108
18. Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR. Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry 2002;59:131-136 (Pubitemid 34137380)
19. Kripke DF. Possibility that certain hypnotics might cause cancer in skin. J Sleep Res 2008;17:245-250
20. Morgan K. Sleep and aging. In: Lichstein KL, Morin CM, eds. Treatment of late-life insomnia. Thousand Oaks, CA: Sage Publications Inc; 2000:3-36.
21. Rosen RC, Rosekind M, Rosevear C, Cole WE, Dement WC. Physician education in sleep and sleep disorders: a national survey of U.S. medical schools. Sleep 1993;16:249-254 (Pubitemid 23119049)
22. Ancoli-Israel S, Roth T. Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I. Sleep 1999;22(Suppl 2):S347-53.
23. Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA 1989;262:1479-1484
24. Ohayon MM. Prevalence of DSM-IV diagnostic criteria of insomnia: distinguishing insomnia related to mental disorders from sleep disorders. J Psychiatr Res 1997;31:333-346
25. Ohayon MM. Epidemiology of insomnia: What we know and what we still need to learn. Sleep Med Rev 2002;6:97-111.
26. Pallesen S, Nordhus IH, Nielsen GH, et al. Prevalence of insomnia in the adult Norwegian population. Sleep 2001;24:771-779 (Pubitemid 32979732)
27. Sivertsen B, Omvik S, Pallesen S, Nordhus IH, Bjorvatn B. Søvnlidelser hos eldre som bruker sovemiddel hver kveld. Tidsskr Nor Laegeforen 2004;124:2600-2602 (Pubitemid 40311026)
28. Omvik S, Sivertsen B, Pallesen S, Bjorvatn B, Havik OE, Nordhus IH. Daytime functioning in older patients suffering from chronic insomnia: treatment outcome in a randomized controlled trial comparing CBT with zopiclone. Behav Res Ther 2008;46:623-641
29. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198
30. First MB, Spitzer, R. L, Gibbon, M., & Williams, J. B. W. Structural clinical interview for DSM-IV axis I disorders. New York, NY: Biometrics Research Department; 1995.
31. Agnew HW, Jr., Webb WB, Williams RL. The first night effect: an EEG study of sleep. Psychophysiology 1966;2:263-266
32. Rechtschaffen A, Kales A. A Manual of Standardized Terminology and Scoring System for Sleep Stages of Human Sleep. Los Angeles, CA: Brain Information Service/Brain Research Institute; 1968.
33. Ancoli-Israel S, Kripke DF, Klauber MR, et al. Morbidity, mortality and sleep-disordered breathing in community dwelling elderly. Sleep 1996;19:277-282 (Pubitemid 26157500)
34. Phillips BA, Berry DT, Lipke-Molby TC. Sleep-disordered breathing in healthy, aged persons. Fifth and final year follow-up. Chest 1996;110:654-658
35. Recording and scoring leg movements. The Atlas Task Force. Sleep 1993;16:748-759
36. Lichstein KL, Riedel BW. Behavioral assessment and treatment of insomnia: a review with an emphasis on clinical application. Behav Therapy 1994;25:659-688
37. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571
38. Groth M. The Handbook of Psychological Assessment, 2nd ed. New York, NY: Wiley; 1990.
39. Spielberger C. State-Trait Anxiety Inventory: Test Manual. Palo Alto, CA: Consulting Psychological Press, Inc; 1983.
40. Mouret J. Effets de la zopiclone sur l'architecture du sommeil: revue de 19 etude. In: Bordier M, ed. Zopiclone. 1987-1992:5 annees de pratique clinique. Paris, France: Elsevier; 1992:6-7.
41. Mouret J, Ruel D, Maillard F, Bianchi M. Zopiclone versus triazolam in insomniac geriatric patients: a specific increase in delta sleep with zopiclone. Int Clin Psychopharmacol 1990;5(Suppl 2):47-55.
42. Parrino L, Terzano MG. Polysomnographic effects of hypnotic drugs. A review. Psychopharmacology (Berl) 1996;126:1-16.
43. Mamelak M, Csima A, Price V. Effects of zopiclone on the sleep of chronic insomniacs. Pharmacology 1983;27(Suppl 2):156-164 (Pubitemid 14181637)
44. Quadens O, Hoffman G, Buytaert G. Effects of zopiclone as compared to flurazepam on sleep in women over 40 years of age. Pharmacology 1983;27(Suppl 2):146-155 (Pubitemid 14181636)
45. Irwin MR, Cole JC, Nicassio PM. Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middle-aged adults and in older adults 55+ years of age. Health Psychol 2006;25:3-14.
46. Morin CM, Culbert JP, Schwartz SM. Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy. Am J Psychiatry 1994;151:1172-1180
47. Murtagh DR, Greenwood KM. Identifying effective psychological treatments for insomnia: a meta-analysis. J Consult Clin Psychol 1995;63:79-89.
48. Morin CM, Colecchi C, Stone J, Sood R, Brink D. Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA 1999;281:991-999 (Pubitemid 29143890)
49. Pallesen S, Nordhus IH, Kvale G. Nonpharmacological interventions for insomnia in older adults: A meta-analysis of treatment efficacy. Psychotherapy 1998;35:472-482 (Pubitemid 29227719)
50. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002;165:1217-1239 (Pubitemid 34461732)
51. Babu AR, Herdegen J, Fogelfeld L, Shott S, Mazzone T. Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. Arch Intern Med 2005;165:447- (Pubitemid 40280202)
52. Goncalves MA, Guilleminault C, Ramos E, Palha A, Paiva T. Erectile dysfunction, obstructive sleep apnea syndrome and nasal CPAP treatment. Sleep Med 2005;6:333-339 (Pubitemid 40867824)
53. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342:1378-1384 (Pubitemid 30262394)
54. Hung J, Whitford EG, Parsons RW, Hillman DR. Association of sleep apnoea with myocardial infarction in men. Lancet 1990;336:261-264 (Pubitemid 20229120)
55. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005;353:2034-2041 (Pubitemid 41609096)
56. Young T, Blustein J, Finn L, Palta M. Sleep-disordered breathing and motor vehicle accidents in a population-based sample of employed adults. Sleep 1997;20:608-613 (Pubitemid 27449598)
57. Ballester E, Badia JR, Hernandez L, et al. Evidence of the effectiveness of continuous positive airway pressure in the treatment of sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999;159:495-501. (Pubitemid 29084871)
58. Engleman HM, Kingshott RN, Wraith PK, Mackay TW, Deary IJ, Douglas NJ. Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep Apnea/Hypopnea syndrome. Am J Respir Crit Care Med 1999;159:461-467
59. Aikens JE, Caruana-Montaldo B, Vanable PA, Tadimeti L, Mendelson WB. MMPI correlates of sleep and respiratory disturbance in obstructive sleep apnea. Sleep 1999;22:362-369
60. Sivertsen B, Øverland S, Glozier N, Bjorvatn B, Mæland J, Mykletun A. The effect of obstructive sleep apnoea syndrome on sick leave and work disability. Eur Respir J 2008;32:1497-1503
61. Hanly P, Powles P. Hypnotics should never be used in patients with sleep apnea. J Psychosom Res 1993;37(Suppl 1):59-65. (Pubitemid 23084244)
62. Guilleminault C. Clinical features and evaluation of obstructive sleep apnea. In: Kryger MH, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine. Philadelphia, PA: WB Saunders; 1989:552-559
63. Fietze I, Quispe-Bravo S, Hansch T, Rottig J, Baumann G, Witt C. Arousals and sleep stages in patients with obstructive sleep apnoea syndrome: changes under nCPAP treatment. J Sleep Res 1997;6:128-133 (Pubitemid 27300271)